Exane BNP Paribas initiated coverage of Clorox with an Underperform rating and $130 price target. The company’s demand trends have been “stubbornly slow” to recover from last summer’s cyber attack, the analyst tells investors in a research note. The firm also believes Clorox’s margin story will take time to play out while its outsized exposure to private label is concerning.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Argus looking for more favorable entry point in Clorox
- Rising Digital Threats Make CyberArk Software Stock (NASDAQ:CYBR) Almost a No-Brainer
- Clorox price target lowered to $135 from $140 at Wells Fargo
- Clorox price target lowered to $132 from $136 at Barclays
- Clorox price target lowered to $150 from $155 at Citi